BSG and neoplasm: Increasing EMMPRIN expression upregulated the β -catenin signaling pathway and silencing EMMPRIN inhibited β -catenin signaling, cell migration, proliferation, anchorage-independent growth and tumor growth in a mouse tumor xenograft model [26].